FDA scientists say benefits of Pfizer Covid-19 vaccine ‘clearly outweigh’ the risks for children ages 5 to 11

Scientists at the Food and Drug Administration presented an analysis late Friday showing that the protection offered to children between the ages of 5 and 11 by the Covid vaccine developed by Pfizer and BioNTech “would clearly outweigh” the risk of myocarditis, a heart-related side effect, that the vaccine appears to cause.